International Dermatology Outcome Measures (IDEOM) is dedicated to developing evidence-based outcome measures to evaluate the impact of treatments for patients with dermatological diseases. By creating standardized measures, IDEOM aims to improve patient access to effective therapies, guide treatment recommendations, and inform payers regarding the efficacy of treatments.
2013
46-3494056
$2.508 million
IDEOM connects diverse stakeholders to establish patient-centered measurements.
Join us for the IDEOM 12th Annual Meeting on June 27-28, 2025, in Washington, DC.
Dr. Alice B. Gottlieb received the 2023 Master Dermatologist Award.
2025-01-12
Join us for the AID 2025 Dermatology Summit on January 12, 2025, in San Francisco, CA.
Learn More2024-09-20
Attend the hybrid symposium on pruritus on September 20-21, 2024.
Learn More2025-06-27
IDEOM's 12th Annual Meeting from June 27-28, 2025, featuring crucial discussions on dermatology outcomes.
Learn MoreOverall Score
53
44
/100
Program Expense Ratio
88.24%
20
/20
Program Revenue Growth
-68.75%
2
/20
Leverage Ratio
0
2
/20
Working Capital Ratio
6.107
18
/20
Fundraising Efficiency
0
2
/20
Fiscal Year:2022
Source:Source: Self-reported by organization
Category | Amount | Percentage |
---|---|---|
Contributions, Gifts, and Grants | 520K | 90.52% |
Program Services | 2.5K | 0.44% |
Investment Income | 3.463K | 0.60% |
Sales of Non-Inventory Assets | 0 | 0.00% |
Other Notable Sources | 500 | 0.09% |
Total Revenue | 574.4K | 100.00% |
Med Research
Medical Research AdvocacyMed Research
Medical Research AdvocacyMed Research
Medical Research AdvocacyMed Research
Medical Research AdvocacyMed Research
Medical Research Advocacy